{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:28:38Z","timestamp":1777408118501,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence","award":["MOHW105-TDU-B-212-133019"],"award-info":[{"award-number":["MOHW105-TDU-B-212-133019"]}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academia Sinica Taiwan Biobank Stroke Biosignature Project","award":["BM10501010037"],"award-info":[{"award-number":["BM10501010037"]}]},{"name":"NRPB Stroke Clinical Trial Consortium","award":["MOST 104-2325-B-039-005"],"award-info":[{"award-number":["MOST 104-2325-B-039-005"]}]},{"name":"Tseng-Lien Lin Foundation, Taichung, Taiwan"},{"name":"Taiwan Brain Disease Foundation, Taipei, Taiwan"},{"name":"Katsuzo and Kiyo Aoshima Memorial Funds, Japan"},{"name":"China Medical University Hospital Cancer Research Center of Excellence","award":["MOHW105-TDU-B-212-134003"],"award-info":[{"award-number":["MOHW105-TDU-B-212-134003"]}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.schres.2017.01.019","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T10:21:35Z","timestamp":1484648495000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Female schizophrenia patients and risk of breast cancer: A population-based cohort study"],"prefix":"10.1016","volume":"188","author":[{"given":"Ana Isabel","family":"Wu Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.01.019_bb0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1010539513488795","article-title":"Risk factors of breast cancer: a systematic review and meta-analysis","volume":"25","author":"Anothaisintawee","year":"2013","journal-title":"Asia Pac. J. Public Health"},{"key":"10.1016\/j.schres.2017.01.019_bb9000","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","author":"Austin","year":"2009","journal-title":"Statist. Med."},{"key":"10.1016\/j.schres.2017.01.019_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2013.02.019","article-title":"Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study","volume":"150","author":"Bai","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2017.01.019_bb0015","first-page":"3796","article-title":"Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses","volume":"52","author":"Brandes","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.schres.2017.01.019_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-069X-11-87","article-title":"Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case-control study","volume":"11","author":"Brophy","year":"2012","journal-title":"Environ. Health"},{"key":"10.1016\/j.schres.2017.01.019_bb0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/070674371005501203","article-title":"Schizophrenia and cancer: in 2010 do we understand the connection?","volume":"55","author":"Bushe","year":"2010","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2017.01.019_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"Catal\u00e1-L\u00f3pez","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2017.01.019_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2008.01163.x","article-title":"Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis","volume":"117","author":"Catts","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.01.019_bb0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2011.02.018","article-title":"The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study","volume":"129","author":"Chou","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.019_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/070674370104600610","article-title":"Body mass index in persons with schizophrenia","volume":"46","author":"Coodin","year":"2001","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2017.01.019_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/acps.12459","article-title":"Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review","volume":"133","author":"De Hert","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.01.019_bb0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.amjsurg.2012.06.013","article-title":"Breast cancer in patients with schizophrenia","volume":"206","author":"Farasatpour","year":"2013","journal-title":"Am. J. Surg."},{"issue":"18","key":"10.1016\/j.schres.2017.01.019_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1192\/S0007125000297080","article-title":"Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries","author":"Gulbinat","year":"1992","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2017.01.019_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/15622975.2012.739708","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects","volume":"14","author":"Hasan","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.schres.2017.01.019_bb0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/schbul\/sbs065","article-title":"Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden","volume":"39","author":"Ji","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.01.019_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.020","article-title":"Interplay between progesterone and prolactin in mammary development and implications for breast cancer","volume":"357","author":"Lee","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.schres.2017.01.019_bb0090","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marwaha","year":"2004","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2017.01.019_bb0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/bmj.317.7161.784","article-title":"Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study","volume":"317","author":"McCreadie","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2017.01.019_bb0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1192\/bjp.bp.114.147629","article-title":"Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake","volume":"205","author":"Mitchell","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.rpsm.2015.11.003","article-title":"Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia","volume":"9","author":"Montejo","year":"2016","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2017.01.019_bb9005","first-page":"11","article-title":"Performing a 1:N case-control match on propensity score","volume":"29","author":"Parsons","year":"2001","journal-title":"SUGI"},{"key":"10.1016\/j.schres.2017.01.019_bb0115","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2017.01.019_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0269881107087346","article-title":"Antipsychotics and hyperprolactinaemia: clinical recommendations","volume":"22","author":"Peveler","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.01.019_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/jamapsychiatry.2013.268","article-title":"Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings","volume":"70","author":"Power","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0130","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2015"},{"key":"10.1016\/j.schres.2017.01.019_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia","volume":"69","author":"Tiihonen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.019_bb0140","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/cncr.24383","article-title":"Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study","volume":"115","author":"Tran","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.schres.2017.01.019_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archpsyc.59.12.1147","article-title":"Dopamine antagonists and the development of breast cancer","volume":"59","author":"Wang","year":"2002","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:15:21Z","timestamp":1568726121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417300282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":31,"alternative-id":["S0920996417300282"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female schizophrenia patients and risk of breast cancer: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}